DALIAN/BEIJING -- China is on track to conduct final clinical trials for a coronavirus vaccine in 18 countries by the end of the year, bolstering its vaccine diplomacy in emerging economies that are struggling to contain the virus.
Beijing targets Belt and Road countries but safety concerns persist
A COVID-19 vaccine candidate from Sinovac Biotech. Three Chinese companies are now conducting Phase 3 trials abroad. © Reuters
DALIAN/BEIJING -- China is on track to conduct final clinical trials for a coronavirus vaccine in 18 countries by the end of the year, bolstering its vaccine diplomacy in emerging economies that are struggling to contain the virus.